Sundar PichaiSundar Pichai earned $164M in 2023

Kenneth Reali is the former CEO of Bioventus, where he led the company from April 2020 until April 2023. He has a solid foundation in business, holding a Bachelor of Science in Business Administration from Valparaiso University. During his time...

Quick Links
B

Kenneth Reali

Ex-CEO of Bioventus

Education

Bachelor of Science in Business Administration from Valparaiso University

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Bioventus for

3 years 0 months (Apr 2020 - Apr 2023)

Previous Experience

President and CEO of Clinical Innovations, LLC

Rivals

Competitors/colleagues of Kenneth Reali

Holdings

See how much did Kenneth Reali make over time.

During his time as CEO, Kenneth Reali saw fluctuations in his holdings related to Bioventus. In 2021, his insider trades varied significantly, with transactions consistently above $160K, peaking at nearly $1.5M in March 2022. This suggests that he was actively...

Mar 17, 2025

Total Stock Sold

$15.99K

BVS

$15.99K

9,811 BVS shares

What if they kept their stock?

If Kenneth Reali didn't sell their stock, today they would have:
Extra BVS9,811 shares worth $188.47K.
This is 1,078.53% and $172.48K more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Kenneth Reali.

BVS

$13.62K

BVS at $1.39/share

Mar 14, 2022

Sale

BVS

$26.66K

BVS at $14.81/share

Sep 9, 2021

Purchase

BVS

$121.88K

BVS at $13.00/share

Feb 11, 2021

Purchase

Compensation History

See how much did Kenneth Reali make over time.

Kenneth Reali's compensation at Bioventus highlighted the challenges of leading a publicly traded company. In 2021, his total compensation was around $12.6 million, largely driven by stock options, but by 2022, that fell to about $4.4 million with no bonus awarded due to unmet financial targets. His final pay package in 2023, right before his departure, included a salary of $193,151 and a significant bonus component related to his separation. While the numbers are large, they also tell a story about fluctuating company performance. Reali’s compensation package reflects both the potential rewards of successful leadership and the risks that come with underperformance in the firm’s objectives. Given his departure and the peculiar dynamics of executive pay, it’s clear that navigating this landscape demands more than just effective strategy; it requires alignment between leadership and financial outcomes.

Year

2023

Total Compensation

$1.32M

Salary

$193.15K

Board Justification

The compensation philosophy is designed to align executive compensation with company performance and retention strategies, ensuring that executives are rewarded for achieving key performance metrics.

Bonus

$548.81K

Board Justification

The bonus includes a 2023 component paid as part of Mr. Reali’s separation agreement.

Other

$578.01K

Board Justification

Other compensation includes severance payments and COBRA payments made in connection with Mr. Reali’s separation from the Company.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards vested in 2023 as Mr. Reali's employment ended before any stock grants could vest.

Performance Metrics

Performance metrics for the CEO's compensation are based on the achievement of corporate and personal performance objectives.

Other Bioventus CEOs

Here are other CEOs of Bioventus